Treatment of experimental autoimmune encephalomyelitis in SJL/J mice with a replicative HSV-1 vector expressing interleukin-5. (Q43735065)

26 November 2017

title

Treatment of experimental autoimmune encephalomyelitis in SJL/J mice with a replicative HSV-1 vector expressing interleukin-5. (English)

1 reference

Herpes simplex virus type 1

26 November 2017

main subject

1 reference

experimental autoimmune encephalomyelitis

inferred from title

1 reference

5

1 reference

26 November 2017

M Nygårdas

1

1 reference

26 November 2017

C Aspelin

2

1 reference

26 November 2017

H Paavilainen

3

1 reference

26 November 2017

M Röyttä

4

1 reference

26 November 2017

V Hukkanen

6

1 reference

26 November 2017

publication date

17 February 2011

1 reference

26 November 2017

1 reference

26 November 2017

volume

18

1 reference

26 November 2017

issue

7

1 reference

26 November 2017

page(s)

646-655

1 reference

T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system.

26 November 2017

cites work

1 reference

Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

21 January 2018

1 reference

Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.

21 January 2018

1 reference

IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

21 January 2018

1 reference

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

21 January 2018

1 reference

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

21 January 2018

1 reference

Immunopathogenesis of multiple sclerosis

21 January 2018

1 reference

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

21 January 2018

1 reference

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

21 January 2018

1 reference

Natural regulatory T cells: mechanisms of suppression

21 January 2018

1 reference

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

21 January 2018

1 reference

T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis.

21 January 2018

1 reference

Central Nervous System Delivery of Interleukin 4 by a Nonreplicative Herpes Simplex Type 1 Viral Vector Ameliorates Autoimmune Demyelination

21 January 2018

1 reference

Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice.

21 January 2018

1 reference

IL-4 is the key regulator in herpes simplex virus-based gene therapy of BALB/c experimental autoimmune encephalomyelitis

21 January 2018

1 reference

Expression of interleukin-4 but not of interleukin-10 from a replicative herpes simplex virus type 1 viral vector precludes experimental allergic encephalomyelitis

21 January 2018

1 reference

Glatiramer acetate (GA) induces IL-13/IL-5 secretion in naive T cells

21 January 2018

1 reference

Correlation of serum IL-13 and IL-5 levels with clinical response to Glatiramer acetate in patients with multiple sclerosis

21 January 2018

1 reference

Glatiramer acetate reduces lymphocyte proliferation and enhances IL-5 and IL-13 production through modulation of monocyte-derived dendritic cells in multiple sclerosis

21 January 2018

1 reference

Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease

21 January 2018

1 reference

Lipopolysaccharide pretreatment modulates the disease course in experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

Latent herpes simplex virus in spinal ganglia of mice

21 January 2018

1 reference

Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture

21 January 2018

1 reference

HSV trafficking and development of gene therapy vectors with applications in the nervous system

21 January 2018

1 reference

Induction of encephalitis in SJL mice by intranasal infection with herpes simplex virus type 1: a possible model of herpes simplex encephalitis in humans

21 January 2018

1 reference

Spread and replication of and immune response to gamma134.5-negative herpes simplex virus type 1 vectors in BALB/c mice

21 January 2018

1 reference

Distinct and Nonredundant In Vivo Functions of IFNAR on Myeloid Cells Limit Autoimmunity in the Central Nervous System

21 January 2018

1 reference

The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice

21 January 2018

1 reference

IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis

21 January 2018

1 reference

Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis

21 January 2018

1 reference

Th2 cytokines down-regulate TLR expression and function in human intestinal epithelial cells

21 January 2018

1 reference

Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis

21 January 2018

1 reference

Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

Herpes simplex virus type 1 infection induces upregulation of interleukin-23 (p19) mRNA expression in trigeminal ganglia of BALB/c mice

21 January 2018

1 reference

A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage

21 January 2018

1 reference

Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).

21 January 2018

1 reference

Enhancement of Th2 responses to replicative herpes simplex virus type 1 vectors by immunomodulative chemotherapy

21 January 2018

1 reference

HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice.

21 January 2018

1 reference

Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins

21 January 2018

1 reference

Immunomodulation by roquinimex decreases the expression of IL-23 (p19) mRNA in the brains of herpes simplex virus type 1 infected BALB/c mice

21 January 2018

1 reference

A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells

21 January 2018

1 reference

7 January 2021

The T lymphocyte in experimental allergic encephalomyelitis

1 reference

7 January 2021

Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor α and tumor necrosis factor β

1 reference

7 January 2021

Anti-IL-12 antibody prevents the development and progression of multiple sclerosis-like relapsing--remitting demyelinating disease in NOD mice induced with myelin oligodendrocyte glycoprotein peptide

1 reference

7 January 2021

Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12

1 reference

7 January 2021

Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis

1 reference

7 January 2021

Interferon γ, interleukin 4 and transforming growth factor β in experimental autoimmune encephalomyelitis in lewis rats: Dynamics of cellular mrna expression in the central nervous system and lymphoid cells

1 reference

7 January 2021

Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination

1 reference

7 January 2021

Experimental autoimmune encephalomyelitis in IL-4-deficient mice

1 reference

7 January 2021

IL-5-deficient mice are susceptible to experimental autoimmune encephalomyelitis

1 reference

7 January 2021

CpG oligonucleotides are potent adjuvants for the activation of autoreactive encephalitogenic T cells in vivo

1 reference

7 January 2021

Cutting Edge: TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFN-beta

1 reference

7 January 2021

Type 1 interferons cool the inflamed brain

1 reference

7 January 2021

In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis

1 reference

7 January 2021

Interferon beta induces T-helper 2 immune deviation in MS

1 reference

7 January 2021

Identifiers

DOI

10.1038/GT.2011.4

1 reference

Dimensions Publication ID

26 November 2017

1008362692

0 references

Fatcat ID

release_6srthek7rvfsxptwziwjkuv34i

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6srthek7rvfsxptwziwjkuv34i

24 November 2022

mapped directly with Wikidata item

1 reference